10th June 2022 | Pharma Updates
US based Olema Pharmaceuticals signs a deal with Dr. Reddy's arm
Dr Reddy’s Laboratories announced that its subsidiary has entered into an agreement with Olema Pharmaceuticals Inc of the United States to research, develop, and commercialise novel small molecule inhibitors of an unnamed oncology target.
As patients inquire about Dostarlimab, cancer experts advise "cautious optimism"
The consequences of the ongoing Dostarlimab clinical trial have everyone excited, as all 12 rectal cancer patients have confirmed a complete medical response with no signs of the tumour after at least six months of follow-up.
Pfizer completed its acquisition of ReViral
Pfizer announced the successful completion of its acquisition of ReViral, a privately held clinical-stage biopharmaceutical company focused on discovering, developing, and commercialising novel antiviral therapeutics that target respiratory syncytial virus (RSV).
GSK relaunches with new purpose, strategy, and brand identity
GSK has a new purpose “to unite science, technology, and talent to get ahead of disease together, ” as well as a new strategy, ambitions, and brand identity.
PGI Chandigarh's tobacco control centre received WHO award
World Health Organization has awarded the Resource Centre for Tobacco Control of the Department of Community Medicine and School of Public Health at the PGIMER in Chandigarh for its efforts in advancing tobacco control.
RIL-Apollo leading the race for Boots pharma chain
A consortium led by Reliance Industries Ltd (RIL) and buyout firm Apollo Global Management Inc. has emerged as the leading bidder for Walgreens Boots Alliance Inc. ‘s Boots pharmacies unit in the United Kingdom.
Gennova closing in on nod for Indian-developed mRNA vaccine
Covid-19, India’s first mRNA-based vaccine, is one step closer to being approved. The country’s drug regulator’s subject expert committee will soon review Pune-based Gennova Biopharmaceuticals’ application for an EUA for its vaccine.